Healthcare & Life Sciences
Rarebird
United Kingdomrarebird.uk
Rarebird is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 1 tracked investor.
activeseries-c-plus
series-c-plus
Stage
2020
Founded
1
Investors
About Rarebird
Rarebird is a company founded in 2020 headquartered in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Rarebird produces coffee that replaces caffeine with paraxanthine (PX), a metabolite of caffeine that provides stimulation without the associated anxiety, sleeplessness, and jitters.
Explore Rarebird's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.